Timothy M Mayleben - Net Worth and Insider Trading
Timothy M Mayleben Net Worth
The estimated net worth of Timothy M Mayleben is at least $363,054 dollars as of 2025-05-15. Timothy M Mayleben is the President and CEO of Vericel Corp and owns about 6,650 shares of Vericel Corp (VCEL) stock worth over $281,295. Timothy M Mayleben is the President & CEO of Esperion Therapeutics Inc and owns about 111,998 shares of Esperion Therapeutics Inc (ESPR) stock worth over $81,759. Timothy M Mayleben is also the Director of Loxo Oncology Inc and owns about 0 shares of Loxo Oncology Inc (LOXO) stock worth over $0. Details can be seen in Timothy M Mayleben's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Timothy M Mayleben has not made any transactions after 2020-03-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Timothy M Mayleben
Timothy M Mayleben Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy M Mayleben owns 6 companies in total, including Esperion Therapeutics Inc (ESPR) , Marinus Pharmaceuticals Inc (MRNS) , and Loxo Oncology Inc (LOXO) among others .
Click here to see the complete history of Timothy M Mayleben’s form 4 insider trades.
Insider Ownership Summary of Timothy M Mayleben
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2020-03-11 | director & Pres & Chief Executive Officer |
| MRNS | Marinus Pharmaceuticals Inc | 2014-07-31 | director |
| LOXO | Loxo Oncology Inc | 2019-02-15 | director |
 | | 2011-08-08 | director & President and CEO |
| | 2006-10-06 | director |
| | 2021-05-13 | director |
Timothy M Mayleben Latest Holdings Summary
Timothy M Mayleben currently owns a total of 3 stocks. Among these stocks, Timothy M Mayleben owns 6,650 shares of Vericel Corp (VCEL) as of August 8, 2011, with a value of $281,295 and a weighting of 77.48%. Timothy M Mayleben owns 111,998 shares of Esperion Therapeutics Inc (ESPR) as of March 11, 2020, with a value of $81,759 and a weighting of 22.52%. Timothy M Mayleben also owns 0 shares of Loxo Oncology Inc (LOXO) as of June 8, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Timothy M Mayleben
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VCEL | Vericel Corp | 2011-08-08 | 6,650 | 42.30 | 281,295 |
| ESPR | Esperion Therapeutics Inc | 2020-03-11 | 111,998 | 0.73 | 81,759 |
| LOXO | Loxo Oncology Inc | 2018-06-08 | 0 | 234.66 | 0 |
Holding Weightings of Timothy M Mayleben
Timothy M Mayleben Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy M Mayleben has made a total of 0 transactions in Vericel Corp (VCEL) over the past 5 years. The most-recent trade in Vericel Corp is the acquisition of 500 shares on August 8, 2011, which cost Timothy M Mayleben around $21,100.
According to the SEC Form 4 filings, Timothy M Mayleben has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 2,500 shares on March 11, 2020, which cost Timothy M Mayleben around $107,500.
According to the SEC Form 4 filings, Timothy M Mayleben has made a total of 0 transactions in Loxo Oncology Inc (LOXO) over the past 5 years. The most-recent trade in Loxo Oncology Inc is the sale of 10,000 shares on June 8, 2018, which brought Timothy M Mayleben around $2 Million.
Insider Trading History of Timothy M Mayleben
- 1
Timothy M Mayleben Trading Performance
GuruFocus tracks the stock performance after each of Timothy M Mayleben's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy M Mayleben is 15.86%. GuruFocus also compares Timothy M Mayleben's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy M Mayleben within 3 months outperforms 14 times out of 20 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy M Mayleben's insider trading performs compared to the benchmark.
Performance of Timothy M Mayleben
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.25 | | | | | |
| Relative Return to S&P 500(%) | 3.44 | | | | | |
Timothy M Mayleben Ownership Network
Ownership Network List of Timothy M Mayleben
Ownership Network Relation of Timothy M Mayleben
Timothy M Mayleben Owned Company Details
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Timothy M Mayleben is the director & Pres & Chief Executive Officer of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Financial Officer Benjamin Halladay , Chief Commercial Officer Eric Warren , and Chief Operating Officer Sheldon L. Koenig .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Timothy M Mayleben made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 11,100 shares made by Eric Warren , a net sale of 6,808 shares made by Benjamin Halladay , and a net sale of 40,044 shares made by Sheldon L. Koenig .
In summary, during the past 3 months, insiders sold 19,381 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 19,381 shares. During the past 18 months, 62,154 shares of Esperion Therapeutics Inc (ESPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 62,154 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
Timothy M Mayleben Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy M Mayleben. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Timothy M Mayleben's mailing address is: Ann Arbor Mi 48108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
